In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease

JA Urbina, G Payares, C Sanoja, R Lira… - International journal of …, 2003 - Elsevier
vivo activities of this compound against Trypanosoma cruzi. Ravuconazole showed very
potent in vitro anti-T… by the Kinetoplastid protozoan Trypanosoma cruzi, responsible for the …

In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds

AMC Canavaci, JM Bustamante… - PLoS neglected …, 2010 - journals.plos.org
… In this work, we describe the development and validation of improved methods to test anti-T.
cruzi compounds in vitro and in vivo using parasite lines expressing the firefly luciferase (luc…

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi

YT Chen, LS Brinen, ID Kerr, E Hansell… - PLoS neglected …, 2010 - journals.plos.org
… Cruzain, the major cysteine protease of Trypanosoma cruzi, is an essential enzyme for
the … T. cruzi infection and is currently a clinical candidate for treatment of Chagas' disease. …

Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models

EM De Souza, TC Araujo-Jorge, C Bailly… - Cell and tissue …, 2003 - Springer
… During the in vivo analysis, we performed both the TUNEL assay, which measures the …
Our present results showed that during the in vivo infection with T. cruzi, cardiac cells undergo …

A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging

MD Lewis, AF Francisco, MC Taylor… - Journal of …, 2015 - journals.sagepub.com
… Validation of in vivo imaging as a tool to assess efficacy of drug treatment against acute
and chronic Trypanosoma cruzi infections. (A) SCID mice infected with 10 3 bioluminescent T. …

In Vitro and In Vivo Biological Effects of Novel Arylimidamide Derivatives against Trypanosoma cruzi

BL Timm, PB da Silva, MM Batista… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Chagas disease (CD), a neglected tropical disease caused by Trypanosoma cruzi , remains
a serious public health problem in several Latin American countries. The available …

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

JS Silva, DR Twardzik, SG Reed - The Journal of experimental medicine, 1991 - rupress.org
… y-mediated killing of the intracellular protozoan parasite Trypanosoma cruzi and on the
course of T. cruzi infection in mice were investigated. Spleen cells from mice with acute T. …

[HTML][HTML] In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi

I Ramírez-Macías, C Marín, R Chahboun… - The American journal …, 2012 - ncbi.nlm.nih.gov
… for their activity against Trypanosoma cruzi. Our results show that … In vivo results were consistent
with those observed in vitro. … effects of these products showed the reduction of the anti-T. …

TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to …

MT de Oliveira, RT Branquinho, GD Alessio… - Acta Tropica, 2017 - Elsevier
… The clonal evolution of Trypanosoma cruzi sustains scientifically the hypothesis of … This
study intended to characterize a range of biological properties of TcI, TcII and TcVI T. cruzi

In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: a multivariate approach

M Strauss, JHS Rodrigues, MSL Presti, PC Bazán… - Experimental …, 2018 - Elsevier
… the combined effect of benznidazole (BZ) and clomipramine (CLO) against different life-stages
of Trypanosoma cruzi in vitro and their efficacy in a murine model. Life-stages of T. …